| A 52‐week randomized safety study of a calcipotriol/betamethasone dipropionate two‐compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of … K Kragballe, J Austad, L Barnes, A Bibby, M De La Brassinne, ... British Journal of Dermatology 154 (6), 1155-1160, 2006 | 208 | 2006 |
| Cosmetic camouflage advice improves quality of life SA Holme, PE Beattie, CJ Fleming British Journal of Dermatology 147 (5), 946-949, 2002 | 177 | 2002 |
| Efficacy of once‐daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris K Kragballe, KL Noerrelund, H Lui, JP Ortonne, G Wozel, T Uurasmaa, ... British Journal of Dermatology 150 (6), 1167-1173, 2004 | 136 | 2004 |
| Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the … K Kragballe, J Austad, L Barnes, A Bibby, M De La Brassinne, ... Dermatology 213 (4), 319-326, 2006 | 120 | 2006 |
| Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome FM Muller, RS Dawe, H Moseley, CJ Fleming Dermatologic surgery 35 (9), 1349-1354, 2009 | 117 | 2009 |
| A pilot study of treatment of lentigo maligna with 5% imiquimod cream CJ Fleming, AM Bryden, A Evans, RS Dawe, SH Ibbotson British Journal of Dermatology 151 (2), 485-488, 2004 | 100 | 2004 |
| NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity H Wang, S Lee, CL Nigro, L Lattanzio, M Merlano, M Monteverde, R Matin, ... British Journal of Cancer 106 (8), 1446-1452, 2012 | 97 | 2012 |
| Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed C Pourreyron, L Reilly, C Proby, A Panteleyev, C Fleming, K McLean, ... PloS one 7 (2), e31827, 2012 | 97 | 2012 |
| Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a … C Fleming, C Ganslandt, L Guenther, A Johannesson, C Buckley, ... European Journal of Dermatology 20 (4), 465-471, 2010 | 94 | 2010 |
| A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low‐risk nodular basal cell carcinoma L Berroeta, C Clark, RS Dawe, SH Ibbotson, CJ Fleming British Journal of Dermatology 157 (2), 401-403, 2007 | 78 | 2007 |
| A randomized, investigator‐masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to … CEM Griffiths, AY Finlay, CJ Fleming, JNWN Barker, F Mizzi, S Arsonnaud Journal of dermatological treatment 17 (2), 90-95, 2006 | 69 | 2006 |
| Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma CL Nigro, H Wang, A McHugh, L Lattanzio, R Matin, C Harwood, N Syed, ... Journal of Investigative Dermatology 133 (5), 1278-1285, 2013 | 65 | 2013 |
| The use of the dermatoscope to identify early melanoma using the three‐colour test RM MacKie, C Fleming, AD McMahon, P Jarrett British Journal of Dermatology 146 (3), 481-484, 2002 | 63 | 2002 |
| Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial K Wolff, C Fleming, J Hanifin, K Papp, S Reitamo, M Rustin, N Shear, ... British Journal of Dermatology 152 (6), 1296-1303, 2005 | 53 | 2005 |
| The genetics of allergic contact hypersensitivity to nickel CJ Fleming, AD Burden, A Forsyth Contact Dermatitis 41 (5), 251-253, 1999 | 52 | 1999 |
| Patch testing in discoid eczema C Fleming, E Parry, A Forsyth, D Kemmett Contact dermatitis 36 (5), 261-264, 1997 | 51 | 1997 |
| HLA‐Cw6‐positive patients with psoriasis show improved response to methotrexate treatment J West, S Ogston, J Berg, C Palmer, C Fleming, V Kumar, J Foerster Clinical and experimental dermatology 42 (6), 651-655, 2017 | 49 | 2017 |
| Dermatoscopic features of benign sebaceous proliferation AM Bryden, RS Dawe, C Fleming Clinical and experimental dermatology 29 (6), 676-677, 2004 | 48 | 2004 |
| Seven years' experience of Mohs micrographic surgery in a UK centre, and development of a UK minimum dataset and audit standards L Macfarlane, A Waters, A Evans, A Affleck, C Fleming Clinical and experimental dermatology 38 (3), 262-269, 2013 | 47 | 2013 |
| Cutaneous manifestations of fucosidosis C Fleming, A Rennie, M Fallowfield, PM McHenry British Journal of Dermatology 136 (4), 594-597, 1997 | 44 | 1997 |
